Treating Patients With Opioid Use Disorder in Their Homes

An Emerging Treatment Model

Published in: JAMA Network (2020). doi: 10.1001/jama.2020.3940

Posted on RAND.org on May 29, 2020

by Lori Uscher-Pines, Haiden A. Huskamp, Ateev Mehrotra

Read More

Access further information on this document at JAMA Network

This article was published outside of RAND. The full text of the article can be found at the link above.

Approximately 50,000 deaths from opioid overdose occur each year in the US, and the prevalence of heroin use is increasing. Although more than 2 million people with an opioid use disorder (OUD) need treatment and an increasing number of individuals are receiving treatment, less than 20% receive effective medications such as buprenorphine. Individuals may encounter many barriers to receiving medication treatment including inadequate supply and distribution of clinicians who can provide it, stigma related to drug use, and intensity of traditional OUD treatment. This approach has become even more important in the midst of the worldwide coronavirus 2019 (COVID-19) pandemic. Telehealth for OUD in the home is a new treatment model that has emerged in recent years that may help to address these issues. In this Viewpoint, we discuss what is contributing to the emergence of this new service, the structure of the care, and how recent federal legislation and COVID-19 may accelerate growth.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.